ArticleInternational journal of cancer2021

Outcomes on anti-VEGFR-2/paclitaxel treatment after progression on immune checkpoint inhibition in patients with metastatic gastroesophageal adenocarcinoma.

Lionel A Kankeu Fonkoua et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.